XCUR exicuretx.com: Bozor kapitallashuvining balans qiymatiga nisbati

Exicure Inc. (XCUR) - korporativ logo

Exicure, Inc. (XCUR) litsenziat，《laridan to'lovlarni kutayotgan bir paytda, organizmga zarar yetkazmasdan genetik agentlarni hujayralarga yetkazib berish uchun innovatsion tizimga tayanadi. Kompaniya biofarmatsevtika hamkorlari bilan hamkorlikda immun va teri patologiyalariga qarshi kurashish uchun RNAga asoslangan dori vositalarini ishlab chiqmoqda. Biznes hozirda chuqur restrukturizatsiya va yangi aktivlarni qidirish jarayonidan o'tmoqda, bunda ko'rsatkich 7.13 darajasida turibdi. Baholash vositasi bo'lib xizmat qiluvchi GURU.Markets dagi narxlar grafigi kompaniyaning joriy transformatsiya holatini tasdiqlaydi.

exicuretx.com (XCUR): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 28.10.2026gacha

Exicure, Inc. (XCUR) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi exicuretx.com|XCUR - Adolatli qiymat konsensusi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Exicure Corp|XCUR - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Exicure|XCUR - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati exicuretx.com|XCUR - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Exicure, Inc.|XCUR - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati exicuretx.com|XCUR - Kompaniyaning jamlangan qarzi|Balans kapitallashuviga qarzlar Exicure Corp
Kompaniyaning dastlabki tahlili:Exicure Inc. (XCUR)
Exicure brendining mahsuloti

Ushbu koeffitsient biznesning bozor qiymatining uning sof aktivlaridan qanchalik yuqori ekanligini belgilaydi. Mazkur metrika resurslarni boshqarish samaradorligini ochib berish uchun bozor narxini balans qiymati bilan solishtiradi. GURU.Markets platformasida joriy narxning balans qiymatiga nisbatini tahlil qilish orqali investor kapitalning qadrsizlanish xavfini baholaydi. Exicure, Inc. (XCUR) uchun ushbu ko'rsatkich dori vositalarini yetkazib berish platformasiga tegishli intellektual mulkning bozor tomonidan qayta baholanishini aks ettiradi. Gen terapiyasining litsenziyalash salohiyati kompaniyaning asosiy qo'shimcha kapitalini tashkil etadi.

Raqobatchilar tahlili

Bozor qiymatining balans qiymatiga nisbati Tempus Labs TEM|qiagen.com (QGEN) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati RGEN|Bozor qiymatining balans qiymatiga nisbati Avidity RNA|Kapitallashuvning balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati ultragenyx.com RARE|BEAM (Beam Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Sarepta Therapeutics (SRPT) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Twist Bio|10x (TXG) - Kapitallashuvning balans qiymatiga nisbati|NTLA: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi stoketherapeutics.com|Bozor kapitallashuvining balans qiymatiga nisbati BLFS (BioLife Solutions)|Kapitallashuvning sof aktivlarga nisbati Wave Life Sciences Ltd WVE|Kapitallashuvning sof aktivlarga nisbati MAZE (Maze Tx)|Sionna Corp - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Prime Medicine, Inc. (PRME)|TSHA - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati QURE|Bozor qiymatining balans qiymatiga koeffitsiyenti MeiraGTx Holdings|RGNX - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Solid Corp|OCGN (Ocugen, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi PACB (pacb.com)|BNTC - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Design Therapeutics Inc DSGN|RCKT: Bozor kapitallashuvining balans qiymatiga nisbati|4D Molecular Corp (FDMT) - Kapitallashuvning sof aktivlarga nisbati|lexeotx.com - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Korro Bio|Kapitallashuvning sof aktivlarga nisbati Editas Medicine (EDIT)|Kapitallashuvning balans qiymatiga nisbati Silence Therapeutics PLC|Bozor kapitallashuvining balans qiymatiga nisbati PRQR (ProQR Therapeutics N.V.)|Kapitallashuvning sof aktivlarga nisbati codexis.com CDXS|Kapitallashuvning sof aktivlarga nisbati SGMO (Sangamo Therapeutics)|Nautilus Biotechnology, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Metagenomi (MGX)|DTIL - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati generationbio.com|BOLD (Boundless Bio Inc) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Imunon Inc (IMNN)|Kapitallashuvning balans qiymatiga nisbati RXi Pharmaceuticals|Bozor kapitallashuvining balans qiymatiga nisbati MBIO|Bozor kapitallashuvining balans qiymatiga nisbati transcodetherapeutics.com (RNAZ)|BNGO: Bozor kapitallashuvining balans qiymatiga nisbati|APDN - Bozor qiymatining balans qiymatiga koeffitsiyenti|bluebird bio, Inc. (BLUE) - Kapitallashuvning sof aktivlarga nisbati|IPA - Kapitallashuvning balans qiymatiga nisbati|Omega Therapeutics, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Singular Genomics Systems, Inc. (OMIC) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati RGLS|Kapitallashuvning sof aktivlarga nisbati Syros Pharmaceuticals, Inc (SYRS)|Kapitallashuvning sof aktivlarga nisbati TBIO|Bozor kapitallashuvining balans qiymatiga nisbati TCON (traconpharma.com)|Bozor qiymatining balans qiymatiga nisbati Unity Biotechnology, Inc.